Evofem Bioscience Inc (EVFM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 09-2019 | 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 15,875 | 32,506 | 51,080 | 600 | 1,761 |
| Marketable Securities | 8,233 | 3,715 | N/A | N/A | N/A |
| TOTAL | $26,421 | $37,532 | $52,849 | $1,413 | $2,478 |
| Non-Current Assets | |||||
| PPE Net | 394 | 546 | 461 | 527 | 593 |
| Other Non-Current Assets | 1,480 | 911 | 1,105 | 1,294 | 939 |
| TOTAL | $1,874 | $1,457 | $1,566 | $1,821 | $1,532 |
| Total Assets | $28,295 | $38,989 | $54,415 | $3,234 | $4,010 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 6,008 | 5,163 | 8,567 | 11,933 | 8,882 |
| Accrued Expenses | 6,454 | 9,369 | 9,476 | 15,370 | 14,437 |
| TOTAL | $12,659 | $14,914 | $18,623 | $32,085 | $27,329 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 37 |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $37 |
| Total Liabilities | $12,659 | $14,914 | $18,623 | $32,085 | $27,366 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 26 | 25 | 25 | 19 | 15 |
| Common Shares | 5 | 5 | 5 | 3 | 3 |
| Retained earnings | -513,179 | -500,462 | -486,664 | -451,214 | -433,146 |
| TOTAL | $15,636 | $24,075 | $35,792 | $-28,851 | $-23,356 |
| Total Liabilities And Equity | $28,295 | $38,989 | $54,415 | $3,234 | $4,010 |